FOXP1 and Down syndrome: Thus, we expect that improving associative learning by targeting dysregulated proteins involved in mitochondrial function, electron transport chains, or antioxidants may have a positive impact on both the symptoms of ASD and ID in patients with FOXP1 syndrome.